Unichem Laboratories has received establishment inspection report (EIR), from the US health regulator.

The company’s formulation manufacturing facility at Ghaziabad has received an EIR, from USFDA. The inspection was conducted by United States Food and Drug Administration (USFDA), in April 2018. Furthermore, this EIR means closure of the inspection.

Read EquityPandit’s Technical Analysis of Nifty Pharma Outlook for the Week